Search

Copyright of Diamond & Abrasives Engineering is the property of Zhengzhou Research Institute for Abrasives & Grinding and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Diamond & Abrasives Engineering is the property of Zhengzhou Research Institute for Abrasives & Grinding and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

To investigate the therapeutic effects of abdominal acupuncture on patients with anxiety and depression after coronary heart disease intervention and its effect on anxiety and somatic symptoms. From August 2021 to May 2022, A total of 120 cases of patients with anxiety and depression after coronary heart disease intervention who were diagnosed and treated in Guangdong Provincial Hospital of Traditional Chinese Medicine were selected as the research objects, and the patients were equally divided into the experimental group and the matched group accorded to the 1:1 parallel control principle. The matched group were given routine treatment, and the experimental group were given abdominal acupuncture therapy on the basis of the treatment of the matched group. Both groups were treated and observed for 4 weeks. The anxiety and depression scores of the two groups after treatment were lower than those before treatment, and the experimental group were lower than the matched group (P<0.05). The angina scores of the two groups after treatment were higher than those before treatment, and the experimental group were higher than the matched group (P<0.05). The TCM symptom scores of the experimental group and the matched group after treatment were lower than those before treatment (P<0.05), and the experimental group was also lower than the matched group (P<0.05). The incidence rates of constipation, drowsiness, dizziness, tachycardia and other adverse reactions during the treatment period in the combined group were 3.3 %, compared with 21.7 % in the experimental group, and there were difference compared between the two groups (P<0.05). Abdominal acupuncture in the treatment of patients with anxiety and depression after coronary heart disease intervention can promote the relief of anxiety and depression symptoms, improve the cognitive function of the patients, reduce the occurrence of adverse reactions, improve angina symptoms and reduce TCM symptom scores. [ABSTRACT FROM AUTHOR]

Copyright of Pearl River is the property of Pearl River Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Science & Technology of Cereals, Oils & Foods is the property of Science & Technology of Cereals, Oils & Foods Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To explore Chen's heart failure formula and its application β-Effect of receptor blockers on heart failure in ischemic cardiomyopathy and its effect on cardiac function and 6-minute walk test. Methods: A total of 70 patients with ischemic cardiomyopathy and heart failure treated in our hospital from April 2022 to May 2022 were selected as the research objects, and were randomly divided into heart failure formula group and control group, with 35 patients in each group. The patients in the control group were treated with routine treatment+ β-The patients in the heart failure formula group were treated with Chen's heart failure formula on the basis of the treatment of the control group. The effects of the two treatment schemes on cardiac function and 6-minute walking test were compared. Results: The treatment effective rate of the heart failure formula group(97.1 %) was significantly higher than that of the control group(82.9 %)(P<0.05); After treatment, the cardiac function in both groups was significantly improved, while compared with the control group, the LVEDD and LVESD in the Xinshuaifang group were significantly decreased, and the LVEF was significantly increased (P<0.05); There was no statistical difference in the results of walking test 6 minutes before treatment(P>0.05). After treatment, the results of 6-min walking test in the two groups were significantly longer than those before treatment, and the heart failure formula group was also significantly longer than the control group after treatment(P<0.05); Before treatment, there was no significant difference in BNP level, TCM syndrome score and quality of life score between the two groups(P>0.05). After treatment, the BNP levels, TCM syndrome scores, and quality of life scores in the two groups were significantly decreased, and the heart failure formula group was also significantly lower than the control group(P<0.05). Conclusion: Chen's heart failure formula and β-Receptor blockers are effective in the treatment of ischemic cardiomyopathy with heart failure. They can improve the cardiac function of patients, and the curative effect is better than that of single application β-Receptor blockers are more suitable for the treatment of ischemic cardiomyopathy and heart failure. Clinically, functional combination therapy is actively and widely used. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Practical Electrocardiology is the property of Journal of Practical Electrocardiology Editorial Board and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To investigate the clinical efficacy and mechanism of qiliqiangxin capsule in the treatment of qi deficiency blood stasis coronary heart disease angina pectoris. Methods: From January 2015 to December 2017, 61 cases with qi deficiency blood stasis coronary heart disease angina pectoris in our hospital were chosen and randomly divided into the observation group (31 cases) and the control group (30 cases) according to random numbers table method. The control group was given basic treatment, the observation group was given qiliqiangxin capsule, the clinical efficacy, curative effect of traditional Chinese medicine, ECG efficacy, the changes of serum IL-6 level before and after treatment and incidence of adverse reactions were compared between two groups. Results: After treat­ment, the total clinical efficacy of observation group(93.5%), curative effect of traditional Chinese medicine(67.7%) and ECG efficacy of observation group were significantly higher than those of the control group(73.3%, 40.0%, 70.0%)(P<0.05). The serum IL-6 levels of two groups after treatment were obviously decreased than those before treatment, while the IL-6 level of observation group was lower than that of the control group(P<0.05). No obvious adverse reaction was found in both groups. Conclusions: Qiliqiangxin capsule could effec­tively enhance the clinical symptoms of Chinese and western medicine in the treatment of qi deficiency blood stasis coronary heart dis­ease angina pectoris, improve the heart function with high safety via decreasing the serum IL-6 level. [ABSTRACT FROM AUTHOR]